首頁>台灣股市>藥華藥>財務分析 - 資產負債表
6446
571
TWD
-13.00 (-2.23%)
2024.11.21收盤

藥華藥-資產負債表

總覽價值投資財務分析技術分析交易資訊公司消息
重要指標每月營收損益表資產負債表現金流量表股利資訊財報電子書
資產負債表

合併資產負債表

(TWD千元)截至2024/09/30截至2023/09/30截至2022/09/30截至2021/09/30截至2020/09/30截至2019/09/30截至2018/09/30截至2017/09/30截至2016/09/30
金額%金額%金額%金額%金額%金額%金額%金額%金額%
資產
流動資產
現金及約當現金20,831,81671.48%20,532,62776.38%4,140,14355.76%1,023,23729.42%4,230,00966.17%1,373,06653.52%2,409,24979.84%3,419,25087.95%4,217,56790.45%
按攤銷後成本衡量之金融資產-流動23,0190.08%21,8970.08%00%
應收帳款淨額2,155,9007.4%1,400,7655.21%674,9029.09%391,66811.26%320,2495.01%5040.02%580%550%6070.01%
其他應收款22,6470.08%54,5280.2%22,6110.3%4860.01%
本期所得稅資產109,1800.37%34,2990.13%4640.01%4430.01%1110%6330.02%8250.03%7610.02%1,2040.03%
存貨1,270,0854.36%1,532,4855.7%1,005,45813.54%629,55918.1%467,9507.32%184,8157.2%66,6642.21%55,2361.42%26,1510.56%
預付款項222,9110.76%277,9411.03%151,1362.04%68,2001.96%53,2070.83%57,3422.24%30,2471%17,6840.45%7,6970.17%
其他流動資產62,0840.21%48,6040.18%47,2740.64%48,0671.38%8,1240.13%9,2700.36%1,8670.06%8000.02%5600.01%
流動資產合計24,697,64284.74%23,903,14688.92%6,042,21281.37%2,161,66062.15%5,079,65079.46%1,626,09463.38%2,508,91083.15%3,496,25689.93%4,256,39491.28%
非流動資產
透過其他綜合損益按公允價值衡量之金融資產-非流動119,8460.41%165,6540.62%38,2970.52%42,4351.22%24,3440.38%25,0000.97%
按攤銷後成本衡量之金融資產-非流動24,8680.09%24,5820.09%27,9130.38%27,0600.78%88,2441.38%19,2790.75%35,9851.19%
不動產、廠房及設備2,147,7997.37%1,000,2113.72%465,8846.27%380,75310.95%390,4876.11%393,32215.33%227,6417.54%253,4236.52%298,2456.4%
使用權資產902,4013.1%671,7822.5%494,9476.67%418,94812.04%459,4627.19%332,24312.95%
無形資產252,1670.87%265,2920.99%236,2853.18%244,6667.03%182,1272.85%14,6200.57%15,6260.52%16,2710.42%18,1880.39%
遞延所得稅資產678,6822.33%570,2282.12%00%
其他非流動資產321,1501.1%279,5661.04%119,8731.61%202,8635.83%168,2212.63%154,9456.04%229,3117.6%
預付設備款179,1370.61%155,3590.58%55,8620.75%18,1480.52%15,0860.24%18,9720.74%114,1543.78%27,9620.72%12,9320.28%
其他非流動資產-其他142,0130.49%124,2070.46%64,0110.86%184,7155.31%153,1352.4%135,9735.3%115,1573.82%93,7662.41%73,2791.57%
非流動資產合計4,446,91315.26%2,977,31511.08%1,383,19918.63%1,316,72537.85%1,312,88520.54%939,40936.62%508,56316.85%391,42210.07%406,4988.72%
資產總計29,144,555100%26,880,461100%7,425,411100%3,478,385100%6,392,535100%2,565,503100%3,017,473100%3,887,678100%4,662,892100%
負債及權益
負債
流動負債
短期借款00%20,0000.07%24,8600.33%30,0000.86%00%10,0000.39%00%10,0000.26%10,0000.21%
應付票據470%360%00%400%780%430%3530.01%2430.01%3300.01%
應付帳款131,3470.45%122,1700.45%193,2352.6%130,5333.75%185,6522.9%24,0230.94%13,6250.45%10,3290.27%11,1260.24%
其他應付款888,6143.05%1,252,0524.66%631,6798.51%364,18910.47%449,8757.04%198,8687.75%82,9142.75%
本期所得稅負債00%3,2630.01%00%00%2,3040.04%00%
租賃負債-流動194,5720.67%135,4080.5%79,1961.07%76,2512.19%69,3431.08%56,9392.22%
其他流動負債792,1572.72%645,0072.4%375,4465.06%422,31712.14%189,7042.97%77,6813.03%11,1660.37%
一年或一營業週期內到期長期負債12,4050.04%12,3200.05%12,0990.16%11,5280.33%5,8000.09%5,8000.23%5,8000.19%5,8000.15%5,8000.12%
一年或一營業週期內到期長期借款12,4050.04%12,3200.05%12,0990.16%11,5280.33%5,8000.09%
退款負債-流動366,8081.26%265,3310.99%
其他流動負債-其他412,9441.42%367,3561.37%363,3474.89%410,78911.81%183,9042.88%71,8812.8%5,3660.18%5,9150.15%3,6730.08%
流動負債合計2,006,7376.89%2,177,9368.1%1,304,41617.57%1,031,95529.67%897,81214.04%367,55414.33%108,0583.58%96,3172.48%83,5551.79%
非流動負債
長期借款53,3950.18%65,7970.24%78,0261.05%89,6912.58%75,4001.18%79,7503.11%85,5502.84%91,3502.35%97,1502.08%
遞延所得稅負債80,6060.28%46,8210.17%00%
租賃負債-非流動761,8022.61%557,9052.08%427,8395.76%353,79910.17%397,3716.22%284,57411.09%
其他非流動負債157,7750.54%183,8370.68%204,7302.76%74,5012.14%23,7670.37%3,6590.14%3,9160.13%
淨確定福利負債-非流動11,3810.04%1,1460%3,7640.05%4,3850.13%3,9480.06%3,6590.14%3,9160.13%
其他非流動負債-其他146,3940.5%182,6910.68%200,9662.71%70,1162.02%19,8190.31%00%00%2490.01%1,0590.02%
非流動負債合計1,053,5783.62%854,3603.18%710,5959.57%517,99114.89%496,5387.77%367,98314.34%89,4662.96%95,0852.45%100,2702.15%
負債總計3,060,31510.5%3,032,29611.28%2,015,01127.14%1,549,94644.56%1,394,35021.81%735,53728.67%197,5246.55%191,4024.92%183,8253.94%
權益
歸屬於母公司業主之權益
股本
普通股股本3,411,96411.71%3,395,69912.63%2,851,44138.4%2,635,39375.76%2,632,03141.17%2,192,76685.47%2,191,26072.62%2,188,85056.3%2,183,48746.83%
股本合計3,411,96411.71%3,395,69912.63%2,851,44138.4%2,635,39375.76%2,632,03141.17%2,192,76685.47%2,191,26072.62%2,188,85056.3%2,183,48746.83%
資本公積
資本公積-發行溢價22,271,68376.42%22,450,23083.52%5,862,78078.96%1,348,96838.78%3,442,19953.85%211,5128.24%1,160,90438.47%
資本公積-普通股股票溢價22,271,68376.42%22,450,23083.52%5,862,78078.96%1,348,96838.78%3,442,19953.85%4,067,37487.23%
資本公積-庫藏股票交易457,4331.57%457,4331.7%457,4346.16%00%
資本公積-員工認股權239,7980.82%242,1870.9%401,2635.4%268,4147.72%263,1614.12%205,6968.02%102,5723.4%92,9212.39%127,0892.73%
資本公積-限制員工權利股票528,5721.81%787,7882.93%00%4600.01%4600.01%4600.02%49,1661.63%73,7341.9%176,2743.78%
資本公積合計23,497,48680.62%23,937,63889.05%6,721,47790.52%1,617,84246.51%3,705,82057.97%417,66816.28%1,312,64243.5%2,161,97355.61%4,370,73793.73%
保留盈餘
未分配盈餘(或待彌補虧損)1,737,3645.96%(739,772)-2.75%(4,035,559)-54.35%(1,924,189)-55.32%(1,312,158)-20.53%(755,386)-29.44%(653,994)-21.67%(623,967)-16.05%(1,935,473)-41.51%
保留盈餘合計1,737,3645.96%(739,772)-2.75%(4,035,559)-54.35%(1,924,189)-55.32%(1,312,158)-20.53%(755,386)-29.44%(653,994)-21.67%(623,967)-16.05%(1,935,473)-41.51%
其他權益
其他權益合計242,5340.83%6,0060.02%(39,457)-0.53%(55,866)-1.61%(27,508)-0.43%(25,082)-0.98%(29,959)-0.99%(30,580)-0.79%(139,684)-3%
庫藏股票(2,805,108)-9.62%(2,751,406)-10.24%(87,502)-1.18%(344,741)-9.91%00%00%00%00%
歸屬於母公司業主之權益合計26,084,24089.5%23,848,16588.72%5,410,40072.86%1,928,43955.44%4,998,18578.19%1,829,96671.33%2,819,94993.45%3,696,27695.08%4,479,06796.06%
權益總額26,084,24089.5%23,848,16588.72%5,410,40072.86%1,928,43955.44%4,998,18578.19%1,829,96671.33%2,819,94993.45%3,696,27695.08%4,479,06796.06%
負債及權益總計29,144,555100%26,880,461100%7,425,411100%3,478,385100%6,392,535100%2,565,503100%3,017,473100%3,887,678100%4,662,892100%
預收股款(權益項下)之約當發行股數00%00%00%00%00%00%00%00%00%
母公司暨子公司所持有之母公司庫藏股股數(單位:股)8,905,0000.03%8,745,0000.03%904,0000.01%3,839,0000.11%00%00%00%00%00%
需注意:由於會計政策的變動,部分現行會計科目在過往資料中,可能名稱不同,或是合併於其他科目中。此外,過往會計科目也可能消失。 然而我們盡力確保表中各項目之數值與公司公布之財報相符。以上資訊僅供參考,實際數據仍以公司公布之財報為準。

資產總額

藥華藥(6446) 截至2024年第3季「資產總額」總計約為NT$291億元,相較上一季增加約NT$9.49億元、相較去年年末增加約NT$18.75億元
藥華藥(6446) 2024年第3季財報顯示公司「資產總額」約NT$291億元;負債總額約NT$30.6億元、為資產總額的10.5%;權益總額約NT$261億元、為資產總額的89.5%。
對比上一季
上一季的(2024年第2季)「資產總額」則為NT$282億元;負債總額約NT$28.76億元、為資產總額的10.2%;權益總額約NT$253億元、為資產總額的89.8%。 今年第3季相較上一季「資產總額」增加約NT$9.49億元。
對比去年年末
去年年末的「資產總額」則為NT$273億元;負債總額約NT$33.21億元、為資產總額的12.18%;權益總額約NT$239億元、為資產總額的87.82%。 今年第3季相較去年年末「資產總額」增加約NT$18.75億元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
資產總額29,144,555100%28,195,318100%27,234,803100%27,269,317100%26,880,461100%27,610,667100%16,571,596100%15,332,628100%7,425,411100%7,343,613100%5,542,024100%6,198,183100%3,478,385100%4,053,829100%4,740,986100%5,531,186100%6,392,535100%4,439,156100%2,659,747100%2,959,410100%2,565,503100%2,728,391100%2,858,926100%2,805,043100%3,017,473100%3,218,954100%3,439,329100%3,669,176100%3,887,678100%4,045,612100%4,270,600100%4,498,534100%4,662,892100%1,431,474100%1,582,870100%1,040,599100%1,384,909100%1,658,813100%
負債總額3,060,31510.5%2,876,47310.2%2,821,46310.36%3,321,16712.18%3,032,29611.28%2,372,6668.59%4,422,70926.69%3,191,41320.81%2,015,01127.14%1,728,99123.54%1,523,20427.48%1,947,80231.43%1,549,94644.56%1,437,76735.47%1,588,43233.5%1,611,47629.13%1,394,35021.81%1,085,65724.46%671,01425.23%704,33423.8%735,53728.67%659,09724.16%628,46821.98%333,08411.87%197,5246.55%182,6755.67%190,5615.54%211,6915.77%191,4024.92%163,1794.03%174,5374.09%228,1495.07%183,8253.94%164,85611.52%299,15218.9%351,03833.73%239,10817.27%190,24811.47%
權益總額26,084,24089.5%25,318,84589.8%24,413,34089.64%23,948,15087.82%23,848,16588.72%25,238,00191.41%12,148,88773.31%12,141,21579.19%5,410,40072.86%5,614,62276.46%4,018,82072.52%4,250,38168.57%1,928,43955.44%2,616,06264.53%3,152,55466.5%3,919,71070.87%4,998,18578.19%3,353,49975.54%1,988,73374.77%2,255,07676.2%1,829,96671.33%2,069,29475.84%2,230,45878.02%2,471,95988.13%2,819,94993.45%3,036,27994.33%3,248,76894.46%3,457,48594.23%3,696,27695.08%3,882,43395.97%4,096,06395.91%4,270,38594.93%4,479,06796.06%1,266,61888.48%1,283,71881.1%689,56166.27%1,145,80182.73%1,468,56588.53%

流動資產

藥華藥(6446) 截至2024年第3季「流動資產」總計約為NT$247億元,相較上一季增加約NT$8.84億元、相較去年年末增加約NT$18.01億元
藥華藥(6446) 2024年第3季財報顯示公司「流動資產」總計約NT$247億元、約佔整體資產的84.74%。
對比上一季
上一季流動資產總計約NT$238億元、約佔整體資產的84.46%。今年第3季相較上一季增加約NT$8.84億元。
對比去年年末
去年年末流動資產則為NT$229億元、約佔整體資產的83.96%。今年第3季相較去年年末增加約NT$18.01億元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
流動資產24,697,64284.74%23,813,25584.46%22,844,28383.88%22,896,15883.96%23,903,14688.92%25,085,63390.85%14,297,88286.28%13,374,97387.23%6,042,21281.37%6,075,81682.74%4,320,79077.96%4,926,66179.49%2,161,66062.15%2,730,60767.36%3,412,23671.97%4,147,42474.98%5,079,65079.46%3,329,21275%1,590,70559.81%1,919,12264.85%1,626,09463.38%1,772,52864.97%1,956,25468.43%2,262,52580.66%2,508,91083.15%2,778,20786.31%3,026,65388%3,259,08188.82%3,496,25689.93%3,651,00690.25%3,868,17090.58%4,086,47890.84%4,256,39491.28%1,011,38570.65%1,153,17172.85%600,63557.72%933,57367.41%1,190,78671.79%

非流動資產

藥華藥(6446) 截至2024年第3季「非流動資產」總計約為NT$44.47億元,相較上一季增加約NT$6,485萬元、相較去年年末增加約NT$7,375萬元
藥華藥(6446) 2024年第3季財報顯示公司「非流動資產」總計約NT$44.47億元、約佔整體資產的15.26%。
對比上一季
上一季非流動資產總計約NT$43.82億元、約佔整體資產的15.54%。今年第3季相較上一季增加約NT$6,485萬元。
對比去年年末
去年年末非流動資產則為NT$43.73億元、約佔整體資產的16.04%。今年第3季相較去年年末增加約NT$7,375萬元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
非流動資產4,446,91315.26%4,382,06315.54%4,390,52016.12%4,373,15916.04%2,977,31511.08%2,525,0349.15%2,273,71413.72%1,957,65512.77%1,383,19918.63%1,267,79717.26%1,221,23422.04%1,271,52220.51%1,316,72537.85%1,323,22232.64%1,328,75028.03%1,383,76225.02%1,312,88520.54%1,109,94425%1,069,04240.19%1,040,28835.15%939,40936.62%955,86335.03%902,67231.57%542,51819.34%508,56316.85%440,74713.69%412,67612%410,09511.18%391,42210.07%394,6069.75%402,4309.42%412,0569.16%406,4988.72%420,08929.35%429,69927.15%439,96442.28%451,33632.59%468,02728.21%

流動負債

藥華藥(6446) 截至2024年第3季「流動負債」總計約為NT$20.07億元,相較上一季增加約NT$1.44億元、相較去年年末減少約NT$-1.45億元
藥華藥(6446) 2024年第3季財報顯示公司「流動負債」總計約NT$20.07億元、約佔整體資產的6.89%。
對比上一季
上一季流動負債總計約NT$18.63億元、約佔整體資產的6.61%。今年第3季相較上一季增加約NT$1.44億元。
對比去年年末
去年年末流動負債則為NT$21.52億元、約佔整體資產的7.89%。今年第3季相較去年年末減少約NT$-1.45億元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
流動負債2,006,7376.89%1,863,0066.61%1,832,6336.73%2,152,0937.89%2,177,9368.1%1,742,8946.31%3,874,96323.38%2,550,34816.63%1,304,41617.57%1,045,58814.24%968,65517.48%1,411,96222.78%1,031,95529.67%938,80323.16%1,072,36322.62%1,086,69919.65%897,81214.04%727,73016.39%317,52011.94%336,67811.38%367,55414.33%277,57310.17%248,4768.69%245,2058.74%108,0583.58%91,7252.85%98,1362.85%117,7623.21%96,3172.48%66,5821.65%75,9161.78%127,7062.84%83,5551.79%64,1374.48%196,91712.44%247,30523.77%132,6189.58%80,7844.87%

非流動負債

藥華藥(6446) 截至2024年第3季「非流動負債」總計約為NT$10.54億元,相較上一季增加約NT$4,011萬元、相較去年年末減少約NT$-1.15億元
藥華藥(6446) 2024年第3季財報顯示公司「非流動負債」總計約NT$10.54億元、約佔整體資產的3.62%。
對比上一季
上一季非流動負債總計約NT$10.13億元、約佔整體資產的3.59%。今年第3季相較上一季增加約NT$4,011萬元。
對比去年年末
去年年末非流動負債則為NT$11.69億元、約佔整體資產的4.29%。今年第3季相較去年年末減少約NT$-1.15億元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
非流動負債1,053,5783.62%1,013,4673.59%988,8303.63%1,169,0744.29%854,3603.18%629,7722.28%547,7463.31%641,0654.18%710,5959.57%683,4039.31%554,54910.01%535,8408.65%517,99114.89%498,96412.31%516,06910.89%524,7779.49%496,5387.77%357,9278.06%353,49413.29%367,65612.42%367,98314.34%381,52413.98%379,99213.29%87,8793.13%89,4662.96%90,9502.83%92,4252.69%93,9292.56%95,0852.45%96,5972.39%98,6212.31%100,4432.23%100,2702.15%100,7197.04%102,2356.46%103,7339.97%106,4907.69%109,4646.6%

權益

藥華藥(6446) 截至2024年第3季「權益」總計約為NT$261億元,相較上一季增加約NT$7.65億元、相較去年年末增加約NT$21.36億元
藥華藥(6446) 2024年第3季財報顯示公司「權益」總計約NT$261億元、約佔整體資產的89.5%。
對比上一季
上一季權益總計約NT$253億元、約佔整體資產的89.8%。今年第3季相較上一季增加約NT$7.65億元。
對比去年年末
去年年末權益則為NT$239億元、約佔整體資產的87.82%。今年第3季相較去年年末增加約NT$21.36億元。
TWD千元截至2024/09/30截至2024/06/30截至2024/03/31截至2023/12/31截至2023/09/30截至2023/06/30截至2023/03/31截至2022/12/31截至2022/09/30截至2022/06/30截至2022/03/31截至2021/12/31截至2021/09/30截至2021/06/30截至2021/03/31截至2020/12/31截至2020/09/30截至2020/06/30截至2020/03/31截至2019/12/31截至2019/09/30截至2019/06/30截至2019/03/31截至2018/12/31截至2018/09/30截至2018/06/30截至2018/03/31截至2017/12/31截至2017/09/30截至2017/06/30截至2017/03/31截至2016/12/31截至2016/09/30截至2016/06/30截至2016/03/31截至2015/12/31截至2015/09/30截至2015/06/30截至2015/03/31截至2014/12/31
金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%金額%
權益26,084,24089.5%25,318,84589.8%24,413,34089.64%23,948,15087.82%23,848,16588.72%25,238,00191.41%12,148,88773.31%12,141,21579.19%5,410,40072.86%5,614,62276.46%4,018,82072.52%4,250,38168.57%1,928,43955.44%2,616,06264.53%3,152,55466.5%3,919,71070.87%4,998,18578.19%3,353,49975.54%1,988,73374.77%2,255,07676.2%1,829,96671.33%2,069,29475.84%2,230,45878.02%2,471,95988.13%2,819,94993.45%3,036,27994.33%3,248,76894.46%3,457,48594.23%3,696,27695.08%3,882,43395.97%4,096,06395.91%4,270,38594.93%4,479,06796.06%1,266,61888.48%1,283,71881.1%689,56166.27%1,145,80182.73%1,468,56588.53%
ifa.ai自當盡力提供正確訊息,但如有疏忽或錯誤遺漏,本公司或關係企業與其任何董事或任何受僱人,恕不負任何法律責任。
line
ifa.ai
基於金融科技的新型態公司
01

個人化服務

提供您最完整的財經數據分析與正確的投資知識,協助您做對的決策
攜手一起重新定義未來